相关实验视频

Updated: Mar 15, 2026

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea

Published on: December 23, 2022

来自Tridax procumbens L.的库马林及其抗炎活性

Lina Zheng¹, Xinyue Liu¹, Jinghui Wu¹

¹School of Pharmacy, Guangdong Pharmaceutical University, Guangzhou 510006, China; Guangdong Engineering Research Center for Lead Compounds & Drug Discovery, Guangdong Pharmaceutical University, Guangzhou 510006, China.

|March 13, 2026

概括

来自Tridax procumbens L.的七种新氨酸通过抑制氧化的产生和促炎介质,显示出显著的抗炎潜力. 化合物6是开发新型抗炎药物的有希望的头.

科学领域:

自然产品化学自然产品化学
药理学药理学是指药理学的学科.
药用化学医学化学

背景情况:

特里达克斯 (Tridax procumbens L.) 是一种具有传统药用历史的植物.
库马林是一种多样化的自然产品类别,以各种生物活动而闻名.
炎症是一种复杂的生物反应,与许多疾病有关.

研究的目的:

从Tridax procumbens L.中分离和鉴定库马林的特征.
为了评估隔离的库马林的抗炎作用.
为了研究强大的抗炎性库马林的作用机制.

主要方法:

使用光谱技术 (NMR,IR,MS) 和计算分析 (DP4+,ECD) 进行库马林的隔离和结构阐明.
在体外抗炎试验测量RAW 264.7巨细胞中氧化产生的抑制,这些巨细胞用脂多糖激发.
涉及评估促炎媒介和NF-κB通路激活的机制研究.

主要成果:

他们分离了22种库马林,其中包括7种新型化合物.
四种化合物,特别是 (2'S,3'S) - 3'-甲基-4'-基 (6),6-基-7-(3,3-二甲基基) 库马林 (18), puberulin (20),和altissimacoumarin N (21),表现出显著的氧化抑制作用.
化合物6通过抑制NF-κB核转位,证明了对促炎媒介 (iNOS,COX-2,IL-1β,IL-6) 的剂量依赖性抑制.

结论:

特里达克斯·普罗坎本斯 (Tridax procumbens L.) 是结构多样化的氨酸的丰富来源.
一些孤立的氨酸具有显著的抗炎性质.
化合物6显示出作为开发针对NF-κB通路的新抗炎疗法的主要化合物的潜力.

关键词:

它具有抗炎活性,具有抗炎活性.阿斯特拉属植物 (Asteraceae) 是一个植物.库马林是一种氨酸.这种植物名为Tridax procumbens L.

更多相关视频

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts

Published on: June 26, 2018

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

相关概念视频

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Inflammation

Inflammation

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...